NRXP CIK: 1719406

NRX Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−37.7
FY22:
−39.8
FY23:
−21.7
FY24:
−10.6
FY25:
−14.1
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
−0.01
FY23:
0.00
FY24:
0
FY25:
−2.81
Change from FY21 to FY25
millions USD
FY21:
63.5
FY22:
32.2
FY23:
6.20
FY24:
7.49
FY25:
23.3
millions USD
FY21:
25.7
FY22:
–
FY23:
−15.5
FY24:
−3.15
FY25:
6.35
(positive)
Change from FY21 to FY24
millions USD
FY21:
−37.7
FY22:
−39.8
FY23:
−21.7
FY24:
−10.6
FY25:
–

All amounts in millions USD Data source:SEC EDGAR